Custom Search
ADVERTISEMENT
Today's Health Headlines
NEW YORK (Reuters) - A massive California verdict in a lawsuit alleging Johnson & Johnson's talc-based products cause cancer has opened a new front in the litigation, upending the company's hopes that the cases were only gaining traction in Missouri, legal experts said.

(Reuters) - Eye doctors who had braced themselves for at least a few patients after a dazzling solar eclipse swept the United States cautiously exhaled on Tuesday, with some hospitals reporting zero cases of damaged vision so far.

SINGAPORE (Reuters) - Seven major drinks companies including Coca-Cola and PepsiCo will limit the sugar content of drinks they sell in Singapore, as part of the city-state's campaign to fight diabetes.

(Reuters) - The chief executive of Philip Morris International said he was "extremely encouraged" by the U.S. Food and Drug Administration's recent proposal to lower nicotine levels in cigarettes and nudge smokers toward less harmful alternatives such as e-cigarettes.

MUMBAI (Reuters) - India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.

(Reuters Health) - People who decide to tackle their cancer using only unconventional methods are likely to die sooner than patients who opt for conventional treatments, according to a new study.

Changing childcare settings can affect sleep
Tue, 22 Aug 2017 17:13:59 -0400
NEW YORK (Reuters Health) - - Inconsistent childcare arrangements can affect toddlers’ sleep at night, a new study suggests.

(Reuters Health) - Voters in counties where life expectancy has stagnated and declined in recent years were more likely to abandon the Democratic Party to help elect U.S. President Donald Trump, a new study suggests.

(Reuters Health) - People who’d like to reduce their daily calories without restrictive dieting should consider taking their coffee with little or no sugar - and savoring the beverage might help in that regard, researchers suggest.

FRANKFURT (Reuters) - AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million euros ($29 million) on a research alliance with German biotech start-up Ethris.

ADVERTISEMENT
Make OUR Portal, YOUR Portal
Username: 
Password:
 Remember Remember me 
Not a Customer? Click here!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
loading